Author | Jonathan S. Berek, MD | OncLive

Author | Jonathan S. Berek, MD


Dr. Berek Discusses the Impact of PARP Inhibitors on Ovarian Cancer

November 10, 2018


Jonathan S. Berek, MD, MMS, Laurie Kraus Lacob Professor, Stanford University School of Medicine, director, Stanford Women’s Cancer Center, senior advisor, Stanford Cancer Institute, discusses the impact of PARP inhibitors on the treatment landscape of ovarian cancer.